Evidence map›Paper›PMID 37126376›Full record

ArticleJMIR cancer2023

The Patient Experience of Acute Lymphoblastic Leukemia and Its Treatment: Social Media Review.

Rebecca Crawford, Slaven Sikirica, Ross Morrison, Joseph C Cappelleri, Alexander Russell-Smith, Richa Shah, Helen Chadwick, Lynda Doward

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Rebecca CrawfordResearch Triangle Institute Health Solutions, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-0489-7754
Slaven SikiricaPfizer Inc, New York City, NY, United States.ORCID https://orcid.org/0000-0001-6631-4166
Ross MorrisonResearch Triangle Institute Health Solutions, Manchester, United Kingdom.ORCID https://orcid.org/0000-0003-1643-2222
Joseph C CappelleriPfizer Inc, New York City, NY, United States.ORCID https://orcid.org/0000-0001-9586-0748
Alexander Russell-SmithPfizer Inc, New York City, NY, United States.ORCID https://orcid.org/0000-0003-1445-8138
Richa ShahPfizer Inc, New York City, NY, United States.ORCID https://orcid.org/0000-0001-8671-2014
Helen ChadwickResearch Triangle Institute Health Solutions, Manchester, United Kingdom.ORCID https://orcid.org/0000-0001-6465-8002
Lynda DowardResearch Triangle Institute Health Solutions, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-6236-469X
Manchester Academic Health Science Centre · GBPfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdult patients with acute lymphoblastic leukemia (ALL) report substantial disease- and treatment-related impacts on their health-related quality of life (HRQOL). Patient-reported information (PRI) shared on social media may provide a distinct opportunity to understand the patient experience outside of formal research contexts and help inform the development of novel therapies.

objectiveThis qualitative social media review aimed to assess PRI shared on social media websites to gain a better understanding of the symptom, HRQOL, and treatment impacts on individuals with ALL.

methodsWe identified English-language posts on 3 patient advocacy websites (Patient Power, The Patient Story, and Leukaemia Care) and YouTube that included PRI about experiences with ALL or ALL treatments shared by adults (aged ≥18 years) with a self-reported ALL diagnosis. Patients' demographic and disease characteristics were extracted from posts (where available), and the posts were analyzed thematically. A network analysis was conducted to delineate possible associations among ALL symptoms, HRQOL impacts, and treatment-related symptoms and impacts.

resultsOf the 935 social media posts identified, 63 (7%) met the review criteria, including 40 (63%) videos, 5 (8%) comments posted in response to videos, and 18 (29%) blog posts. The 63 posts were contributed by 41 patients comprised of 21 (51%) males, 18 females (44%), and 2 (5%) whose gender was not reported. Among the patients, 13 (32%) contributed >1 source of data. Fatigue (n=20, 49%), shortness of breath (n=13, 32%), and bruising (n=12, 29%) were the symptoms prior to treatment most frequently discussed by patients. Patients also reported impacts on personal relationships (n=26, 63%), psychological and emotional well-being (n=25, 61%), and work (n=16, 39%). Although inpatient treatment reportedly restricted patients' independence and social functioning, it also provided a few patients with a sense of safety. Patients frequently relied on their doctors to drive their treatment decisions but were also influenced by family members. The network analysis indicated that disease-related symptoms were primarily associated with patients' physical functioning, activities of daily living, and ability to work, while treatment-related symptoms were primarily associated with emotional well-being.

conclusionsThis social media review explored PRI through a thematic analysis of patient-contributed content on patient advocacy websites and YouTube to identify and contextualize emergent themes in patient experiences with ALL and its treatments. To our knowledge, this is the first study to leverage this novel tool to generate new insights into patients' experiences with ALL. Patients' social media posts suggest that inpatient care for ALL is associated with restricted independence and social functioning. However, inpatient care also provided a sense of safety for some patients. Studies such as this one that capture patients' experiences in their own words are valuable tools to further our knowledge of patient outcomes with ALL.

Indexed as

acute lymphoblastic leukemiaadultdiseaseemotionalfunctioninghealth-related quality of lifeindependenceleukemialymphoblasticqualitative researchsocialsocial mediasymptomstherapytreatmentwell-being

Identifiers

PMID37126376
PMCPMC10186186
OpenAlexW4367601365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.